NAHSE Chicago Event
DescriptionThe 340B Drug Discount Program is a U.S. federal government program created in 1992 that requires drug manufacturers to provide outpatient drugs to eligible health care organizations/covered entities at significantly reduced prices.
This educational session presented by Doc & I will explain why the 340B program is important to patients and patient care organizations and how both can maximize the most from this government program.
POINTS OF DISCUSSION / SPEAKING TOPICS * Current 340B landscape * Common misperceptions surrounding 340B * Prospective decision making vs. retrospective decision analysis * Innovative 340B solutions * Key stakeholders and who's who in 340B * And more... |
|
Company Information
Doc & I is a healthcare software company that improves patient access to pharmaceuticals by providing transparency at the point-of-care to Healthcare Professionals.
The Doc & I solution provides both services and Point-of-Care software to help covered entities maximize their 340B savings via prescription fulfillment at contracted pharmacy locations.
The Doc & I solution provides both services and Point-of-Care software to help covered entities maximize their 340B savings via prescription fulfillment at contracted pharmacy locations.
